Sort
10,766 grants matching “checkpoint inhibitor”
Research Project Pancreatic Cancer
$312,270David G Denardo · Washington University · U54 · FY2023 · CA
Role of persistent type I IFN signaling in immune suppression and tumorigenesis during chronic HIV infection
$312,000Scott G Kitchen · University Of California Los Angeles · R01 · FY2023 · CA
G Protein Regulation of Golgi Structure and Function
$312,000Philip B Wedegaertner · Thomas Jefferson University · R01 · FY2020 · GM
G Protein Regulation of Golgi Structure and Function
$312,000Philip B Wedegaertner · Thomas Jefferson University · R01 · FY2019 · GM
G Protein Regulation of Golgi Structure and Function
$312,000Philip B Wedegaertner · Thomas Jefferson University · R01 · FY2021 · GM
Role of persistent type I IFN signaling in immune suppression and tumorigenesis during chronic HIV infection
$312,000Scott G Kitchen · University Of California Los Angeles · R01 · FY2022 · CA
Role of persistent type I IFN signaling in immune suppression and tumorigenesis during chronic HIV infection
$312,000Scott G Kitchen · University Of California Los Angeles · R01 · FY2021 · CA
Role of persistent type I IFN signaling in immune suppression and tumorigenesis during chronic HIV infection
$312,000Scott G Kitchen · University Of California Los Angeles · R01 · FY2020 · CA
G Protein Regulation of Golgi Structure and Function
$312,000Philip B Wedegaertner · Thomas Jefferson University · R01 · FY2022 · GM
Role of persistent type I IFN signaling in immune suppression and tumorigenesis during chronic HIV infection
$312,000Scott G Kitchen · University Of California Los Angeles · R01 · FY2019 · CA
Development of a B Cell Based Vaccine for the Treatment of Newly Diagnosed Malignant Gliomas
$311,960Catalina Lee Chang · Northwestern University At Chicago · P50 · FY2025 · CA
Development of a B Cell Based Vaccine for the Treatment of Newly Diagnosed Malignant Gliomas
$311,543Catalina Lee Chang · Northwestern University At Chicago · P50 · FY2024 · CA
Clinical specimen tumor-TME acquired resistance
$311,509Trever G Bivona · University Of California, San Francisco · U54 · FY2025 · CA
Duke-UNC Chapel Hill Immunotherapy Training Grant
$311,363Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · T32 · FY2020 · CA
Project 4-Modulating Innate Immunity to Overcome Resistance to PD-1/PD-L1 Blockade
$311,178Harriet M Kluger · Yale University · P50 · FY2022 · CA
Large-Scale Genetic Analyses of Human Cancer
$311,125Victor E Velculescu · Johns Hopkins University · R01 · FY2020 · CA
Large-Scale Genetic Analyses of Human Cancer
$311,125Victor E Velculescu · Johns Hopkins University · R01 · FY2021 · CA
Mechanisms of apoptosis regulation which impede cancer cell death in lung cancer
$311,121King Kwong · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
The MRAD9 Radioresistance Gene
$311,099Howard B Lieberman · Columbia University Health Sciences · R01 · FY2007 · GM
The MRAD9 Radioresistance Gene
$311,099Howard B Lieberman · Columbia University Health Sciences · R01 · FY2008 · GM
The MRAD9 Radioresistance Gene
$311,099Howard B Lieberman · Columbia University Health Sciences · R01 · FY2009 · GM
Function and mechanism of REDD1/mTOR signaling in metabolism and tumorigenesis
$311,062Leif W Ellisen · Massachusetts General Hospital · R01 · FY2014 · CA
Role of the Acetyltransferase p300 in Cellular Responses
$310,788George Washington University · R01 · FY2002 · CA
Role of the Acetyltransferase p300 in Cellular Responses
$310,788Georgetown University · R01 · FY2005 · CA
Detection of microsatellite instability biomarkers for therapeutic clinical trial eligibility
$310,771Sameek Roychowdhury · Ohio State University · UH3 · FY2019 · CA